Smallpox: A disease and a weapon

International Journal of Infectious Diseases

Volumn 8, Issue SUPPL. 2, 2004, Pages 3-

  Alibek, Ken ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE;

BIOLOGICAL WARFARE; CHORDOPOXVIRINAE; CLINICAL FEATURE; CONFERENCE PAPER; CORRELATION ANALYSIS; CROSS REACTION; DISEASE SEVERITY; GENETIC ENGINEERING; HUMAN; INFECTION PREVENTION; MEDICAL RESEARCH; MORTALITY; POXVIRUS; SEROLOGY; SMALLPOX; SMALLPOX VIRUS; TECHNIQUE; VIRUS INFECTION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 7444249572     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2004.09.004     Document Type: Conference Paper

References (15)

1. A. Kowalek, and D. Rudikoff A spotlight on smallpox Clin Derm. 20 2002 376 387
2. R. Whitley Smallpox: a potential agent of bioterrorism Antivir Res. 57 2003 7 12
3. C.W. Dixon Smallpox in Trpolitania, 194. an epidemiological and clinical study of 500 cases, including trials of penicillin treatment J Hyg. 46 1948 351 377
4. E.N. Janoff, and R. Lynfield Smallpox: remembrance of things past, or the coming plague? J Lab Clin Med 142 4 2003 211 215
5. D.A. Henderson, T.V. Inglesby, and J.G. Bartlett Smallpox as a Biological Weapon, Medical and Public Health Management JAMA. 281 1999 2127 2137
6. J.B. Tacker The Once and Future threat of Smallpox 2001 Atlantic Monthly Press New York
7. V.A. Sviatchenko, E.V. Agapov, and I.K. Urmanov The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26SRNA of Venezuelan equine encephalomyelitis virus Vopr Virusol. 38 5 1993 222 226
8. D. Panicali, S.W. Davis, R.L. Weinberg, and E. Paoletti Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin Proc Natl Acad Sci USA 80 17 1983 5364 5368
9. R.M. Kinney, J.J. Esposito, and J.H. Mathews Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge J Virol. 62 12 1988 4697 4702
10. S.N. Shchelkkunov, V.M. Blinov, and L.S. Sandakhchiev Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms FEBS Letters. 319 1-2 1993 80 83
11. A.A. Chepurnov, V.A. Ternovoi, and A.A. Dadaeva Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus Vopr Virusol. 42 3 1997 115 120
12. N.V. Cheshenko, V.S. Petrov, and E.V. Protopopova Recombinant vaccinia virus expressing Japanese encephalitis virus protein E Mol Gen Mikrobiol Virusol. 3 1997 24 27
13. V.I. Chernos, T.S. Vovk, and O.N. Ivanova Insertion mutants of the vaccinia virus. The effect of inactivating E7R and D8L genes on the biological properties of the virus Mol Gen Mikrobiol Virusol. 2 1993 30 34
14. O.I. Serpinskii, G.V. Kochneva, and Urmanov Ikh Construction of recombinant variants of orthopoxviruses by inserting foreign genes into intragenic region of viral genome Mol Biol (Mosk). 30 5 1996 1055 1065
15. R.J. Jackson, A.J. Ramsay, and C.D. Christensen Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox J Virol. 75 3 2001 1205 1210